Furthermore, an analysis of bulk RNA-seq data for LSCs isolated from CML patients also showed that TSPAN32 expression was increased after Imatinib exposure (Fig. 1b). The gene discussed is TSPAN32; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.